CN105943840A - Health care product for reducing blood glucose and reducing fat - Google Patents
Health care product for reducing blood glucose and reducing fat Download PDFInfo
- Publication number
- CN105943840A CN105943840A CN201610304932.4A CN201610304932A CN105943840A CN 105943840 A CN105943840 A CN 105943840A CN 201610304932 A CN201610304932 A CN 201610304932A CN 105943840 A CN105943840 A CN 105943840A
- Authority
- CN
- China
- Prior art keywords
- fructus
- extract
- raw material
- poria
- rhizoma polygonati
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 42
- 210000004369 blood Anatomy 0.000 title claims abstract description 41
- 230000036541 health Effects 0.000 title claims abstract description 35
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 15
- 239000008103 glucose Substances 0.000 title claims abstract description 15
- 230000001603 reducing effect Effects 0.000 title abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 62
- 239000002994 raw material Substances 0.000 claims abstract description 53
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 23
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 230000001476 alcoholic effect Effects 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 239000006286 aqueous extract Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 2
- 240000008027 Akebia quinata Species 0.000 abstract 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 2
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 2
- 241000830535 Ligustrum lucidum Species 0.000 abstract 2
- 244000241872 Lycium chinense Species 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 244000197580 Poria cocos Species 0.000 abstract 2
- 210000003734 kidney Anatomy 0.000 description 31
- 230000000694 effects Effects 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 17
- 239000003814 drug Substances 0.000 description 14
- 239000002775 capsule Substances 0.000 description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 206010012601 diabetes mellitus Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 201000001421 hyperglycemia Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 201000005577 familial hyperlipidemia Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000001291 vacuum drying Methods 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- -1 described reflux Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 101100008049 Caenorhabditis elegans cut-5 gene Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000158728 Meliaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000269435 Rana <genus> Species 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 235000021142 long-term diet Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8965—Asparagus, e.g. garden asparagus or asparagus fern
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a health care product for reducing blood glucose and reducing fat, in particular the health care product. The health care product consists of the following raw materials or extracts of the following raw materials: sky fruits, glossy privet fruits, radix achyranthis bidentatae, radix asparagi, fructus corni, rhizoma polygonati odorati, poria cocos, fructus rubi, fruits of Chinese wolfberry and fiveleaf gynostemma herb, and the parts by weight of the raw materials are as follows: 8-12 parts of the sky fruits, 1-5 parts of the glossy privet fruits, 2-8 parts of the radix achyranthis bidentatae, 3-7 parts of the radix asparagi, 1-5 parts of the fructus corni, 1-3 parts of the rhizoma polygonati odorati, 1-5 parts of the poria cocos, 1-5 parts of the fructus rubi, 1-5 parts of the fruits of Chinese wolfberry and 1-5 parts of the fiveleaf gynostemma herb. The health care product disclosed by the invention is capable of obviously reducing blood glucose and reducing fat.
Description
Technical field
The present invention relates to technical field of health care food, in particular it relates to the health product of a kind of blood sugar lowering fat reducing.
Background technology
In recent years, along with China's rapid development of economy, also there is huge change in the life style of our people
Change.The pollution of environment, the change of dietary structure and bad life habits are all promoting China's hyperlipidemia and high blood
The sickness rate rapid increase of sugar disease, and the trend of rejuvenation of falling ill is obvious.Hyperlipidemia is drawn with hyperglycemia
The complications that rises, sequela harm be not only personal health, and inevitably injure and get home
Front yard happiness and social stability.Clinical reality warns us: hyperlipidemia and hyperglycemia situation occurred frequently have become as me
The public health problem that state is great, is that another serious harm people after cardiovascular and cerebrovascular disease, tumor are good for
The Chronic Non-Communicable Diseases of health.
Hyperlipemia is mutually promoted with hyperglycemia, a lot of diabetes patients all with hyperlipemia, therefore people
Generally diabetes and hyperlipemia are called sister sick, and think that hyperlipidemia is the secondary disease of diabetes.According to system
The diabetic of meter about 40% has disorders of lipid metabolism.It is characterized in that triglyceride increases and high density lipoprotein level
White reduction.When the reason that diabetes cause blood fat to increase is due to diabetes patient's insufficient insulin, internal lipase
Activity is to lower, and therefore easily blood fat increases.On the other hand diabetes itself are same in addition to carbohydrate metabolism disturbance
Time also accompany fat, protein and water, dielectric disorder.Free fatty is often had to mobilize from fat depot
Out, triglyceride and FFA concentrations in blood is made to increase.
Health product for hyperlipidemia, hyperglycemic patients are a lot of in the market, but many health product effects
Inconspicuous, also derive many side effect.
Therefore, this area has good blood sugar lowering fat reducing effect and side effect is little in the urgent need to exploitation is a kind of
Health product.
Summary of the invention
It is an object of the invention to provide and a kind of there are good blood sugar lowering fat reducing effect and the little health product of side effect.
First aspect present invention provides a kind of health product, and described health product contain the extract of raw material or raw material,
Wherein said raw material includes, wherein said raw material includes: Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, Radix Asparagi, mountain
Fructus Corni, Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli,
Further, the weight portion of described raw material is as follows:
To sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae 2-8 part, Radix Asparagi 3-7 part, Fructus Corni 1-5
Part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part.
In another preference, the weight portion of described raw material is as follows:
To sky fruit 9-11 part, Fructus Ligustri Lucidi 1-3 part, Radix Achyranthis Bidentatae 3-6 part, Radix Asparagi 4-7 part, Fructus Corni 1-3
Part, Rhizoma Polygonati Odorati 1-2 part, Poria 2-4 part, Fructus Rubi 1-2.5 part, Fructus Lycii 1-3 part, Herb Gynostemmae Pentaphylli 2-4 part.
In another preference, the weight portion of described raw material is as follows:
To sky fruit 10 parts, Fructus Ligustri Lucidi 2 parts, Radix Achyranthis Bidentatae 5 parts, Radix Asparagi 6 parts, Fructus Corni 2 parts, Rhizoma Polygonati Odorati 1
Part, 3 parts of Poria, Fructus Rubi 2 parts, Fructus Lycii 2 parts, Herb Gynostemmae Pentaphylli 3 parts.
In another preference, described raw material by Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, Radix Asparagi, Fructus Corni,
Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli composition.
In another preference, described health product are capsule preparations, and specification is 0.5g/ capsule.
In another preference, described extract includes: water extract, alcohol extraction thing or aqueous extract.
In another preference, described alcohol extraction thing includes ethanol extraction.
In another preference, described aqueous extract is with the extract of aqueous solvent extraction.
In another preference, described aqueous solvent refers to by water and solvent compatible with water (such as alcohol, including ethanol)
The mixed solvent constituted, wherein water content is 10-99.5wt%, preferably 50-90wt%.
Second aspect present invention provides the combination of a kind of raw material, described combination include following raw material: Xiang Tianguo,
Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, Radix Asparagi, Fructus Corni, Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli, and,
The weight portion of described raw material is as follows:
To sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae 2-8 part, Radix Asparagi 3-7 part, Fructus Corni 1-5
Part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part.
In another preference, the weight portion of described raw material is as follows:
To sky fruit 9-11 part, Fructus Ligustri Lucidi 1-3 part, Radix Achyranthis Bidentatae 3-6 part, Radix Asparagi 4-7 part, Fructus Corni 1-3
Part, Rhizoma Polygonati Odorati 1-2 part, Poria 2-4 part, Fructus Rubi 1-2.5 part, Fructus Lycii 1-3 part, Herb Gynostemmae Pentaphylli 2-4 part.
In another preference, the weight portion of described raw material is as follows:
To sky fruit 10 parts, Fructus Ligustri Lucidi 2 parts, Radix Achyranthis Bidentatae 5 parts, Radix Asparagi 6 parts, Fructus Corni 2 parts, Rhizoma Polygonati Odorati 1
Part, 3 parts of Poria, Fructus Rubi 2 parts, Fructus Lycii 2 parts, Herb Gynostemmae Pentaphylli 3 parts.
Third aspect present invention provides the purposes of the combination of the raw material described in second aspect present invention, is used for making
Make preparation for dropping the health product of hypoglycemia and blood fat.
In another preference, the amount of application of described health product is that 2-8 agent for each person every day is (it is preferred that 3-5
Agent, more preferably, 4 doses), the application dosage of every day is equivalent to 4-8 gram of dry total raw material, is preferably equivalent to
4.5-7.0 gram dry total raw material.
Fourth aspect present invention provides the preparation method of a kind of health product, said method comprising the steps of:
(a) provide raw material, described raw material includes: Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, Radix Asparagi, Fructus Corni,
Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli,
Further, the weight portion of described raw material is as follows: to sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae
2-8 part, Radix Asparagi 3-7 part, Fructus Corni 1-5 part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5
Part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part;
B () provides extract I and extract II;
(c) mixed extract I and extract II, thus prepare described health product.
In another preference, in step (b), include for preparing the raw material of extract I: Xiang Tianguo,
Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, the weight portion of described raw material is as follows: to sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae
2-8 part.
In another preference, in step (b), include for preparing the raw material of extract II: Radix Asparagi,
Fructus Corni, Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli, the weight portion of described raw material is as follows: Tianmen
Winter 3-7 part, Fructus Corni 1-5 part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5
Part, Herb Gynostemmae Pentaphylli 1-5 part.
In another preference, in step (b), the preparation of described extract I includes step:
I () is passed through for the raw material preparing extract I and is pulverized, add alcoholic solution and extract, obtain alcohol extract;
(ii) above-mentioned alcohol extract is concentrated, obtain alcohol extraction concentrated solution, be dried, thus obtain described extract I.
In another preference, in step (i), described alcoholic solution includes ethanol solution.
In another preference, in step (i), the amount of the alcoholic solution of addition is the 2-20 of raw material gross mass
Times, it is preferred that 3-15 times, more preferably, 3-10 times.
In another preference, in step (i), the mass fraction of described alcoholic solution is 10-90%, preferably
Ground, 20-80%, more preferably, 30-70%, more preferably, 55-65%.
In another preference, in step (i), described in be extracted as reflux, extract, described reflux, extract,
Time is 0.1h-8h, it is preferred that 0.2h-5h, more preferably, 0.5h-2h.
In another preference, in step (i), extract 3 times with alcoholic solution.
In another preference, the addition of the alcoholic solution that described extraction is 3 times can be identical, can be different.
In another preference, the addition of the alcoholic solution that described extraction is 3 times is different, and the alcohol every time extracted is molten
Liquid addition is respectively 5-15 times of raw material gross mass, 3-10 times and 1-5 times.
In another preference, the time that described extraction is 3 times can be identical, it is also possible to different.
In another preference, the time that described extraction is 3 times is different, and the time every time extracted is respectively
0.5-2h, 0.5-1h, and 20-30min.
In another preference, in step (ii), described concentration includes decompression and/or is concentrated in vacuo.
In another preference, in step (ii), described in the temperature that is concentrated in vacuo be 20-120 DEG C, preferably
Ground, 40-100 DEG C, more preferably, 50-70 DEG C.
In another preference, in step (ii), described vacuum is-1-0Mpa, it is preferred that
-0.5-0Mpa, more preferably ,-0.1Mpa.
In another preference, in step (ii), described being dried includes vacuum drying.
In another preference, in step (ii), described vacuum drying temperature is 10-200 DEG C, preferably
Ground, 20-150 DEG C, more preferably, 40-80 DEG C.
In another preference, in step (ii), described drying time is 2-30h, it is preferred that 5-28h
, more preferably, 12-24h.
In another preference, dried moisture is less than 15%.
In another preference, in step (b), the preparation of described extract II includes step:
I the raw material being used for preparing extract II is added extraction in aqueous solution by (), obtain Aqueous extracts;
(ii) above-mentioned Aqueous extracts is concentrated, obtain water extracting liquid (thick extractum), be dried, thus carry described in obtaining
Take thing II.
In another preference, in step (i), described aqueous solution is water.
In another preference, in step (i), the amount of the aqueous solution of addition is the 2-20 of raw material gross mass
Times, it is preferred that 3-15 times, more preferably, 4-10 times.
In another preference, in step (i), by extraction with aqueous solution 3 times.
In another preference, the addition of the aqueous solution that described extraction is 3 times can be identical, can be different.
In another preference, the addition of the aqueous solution that described extraction is 3 times is different, and that extracts is water-soluble every time
Liquid addition is respectively 5-10 times of raw material gross mass, 3-8 times and 1-4 times.
In another preference, the time that described extraction is 3 times is identical, for 0.1h-8h, it is preferred that 0.2h-5h,
More preferably, 0.5h-3h.
In another preference, the time that described extraction is 3 times is different, and the time every time extracted is respectively
0.5-3h, 0.5-2h, and 0.5-1h.
In another preference, in step (i), before described extraction, also include extracting preparation
The raw material of thing II soaks the step of 0.5-1h in described aqueous solution.
In another preference, in step (ii), described concentration includes decompression and/or is concentrated in vacuo.
In another preference, in step (ii), described in the temperature that is concentrated in vacuo be 20-120 DEG C, preferably
Ground, 40-100 DEG C, more preferably, 60-80 DEG C.
In another preference, in step (ii), described vacuum is-1-0Mpa, it is preferred that
-0.5-0Mpa, more preferably ,-0.1Mpa.
In another preference, in step (ii), described being dried includes vacuum drying.
In another preference, in step (ii), described vacuum drying temperature is 10-200 DEG C, preferably
Ground, 40-150 DEG C, more preferably, 40-80 DEG C.
In another preference, in step (ii), described drying time is 2-30h, it is preferred that 5-28h,
More preferably, 12-24h.
In another preference, dried moisture is less than 15%.
In another preference, concentrated solution (thick extractum) density obtained after described concentration is 1.1-4, preferably
Ground, 1.2-2, more preferably, 1.24-1.35.
In another preference, in step (c), including step:
I () extract I, extract II mix, pulverize, sieve, obtain extract powder I and extract powder II respectively;
(ii) by extract powder I and extract powder II according to the ratio mix homogeneously of 2:1, and with pharmaceutically can connect
The carrier being subject to mixes, packaging, thus obtains described health product.
In another preference, in described step (i), after described extract I and extract II co-grinding,
Cross 60 mesh sieves.
In another preference, described pharmaceutically acceptable carrier is selected from lower group: microcrystalline Cellulose, lactose,
Magnesium stearate, silicon dioxide, cross-linking sodium carboxymethyl cellulose, hydroxy-methyl cellulose, corn starch, friendship
Connection cellulose, polyoxyethylene sorbitan monoleate or a combination thereof.
In should be understood that within the scope of the present invention, above-mentioned each technical characteristic of the present invention and below (as implemented
Example) in can be combined with each other between each technical characteristic of specifically describing, thus constitute new or preferred skill
Art scheme.As space is limited, the most tired at this state.
Detailed description of the invention
The present inventor, through long-term extensively in-depth study, by a large amount of screenings and test, develops first
A kind of health product with notable blood sugar lowering fat reducing effect, this product has natural, safety and good taste, can have
Effect improves the symptom of hyperglycemia, hyperlipidemia.Complete the present invention on this basis.
Raw material components
Xiang Tianguo: belonging to Meliaceae plant, it is the cleanest that the South Pacific Ocean is originated in source, contaminated minimum Saloman group
Island, wherein minimum to sky fruit yield on you of Rana, more precious.To sky, fruit is cool in nature, antipyretic, convergence,
Without any side effects, for the rareest a kind of plant.Described in " Malaysia's medical herbs catalogue ", its taste
Bitter, puckery, cool in nature, antipyretic, convergence, kernel strong.Its seed has the effect such as blood sugar lowering, blood fat reducing, main
Being used for treating the diseases such as diabetes, hyperlipidemia, endocrine disturbance, long-term taking has and improves physical function, carries
High body immune function, strengthening healthy qi, activating cell, pre-anti-aging, slow down aging are the most useful to human body
Place.
Fructus Ligustri Lucidi: be the Chinese medicine of replenishing kidney-YIN, nourishing the liver to improve visual acuity simply, sweet-bitter flavor, cool in nature, return Liver and kidney warp,
There is nourishing the liver and kidney, merit that tonifying YIN nourishes blood.Modern medicine study proves, Fructus Ligustri Lucidi includes ursolic acid, manna
Alcohol, glucose, fatty oil etc., have heart tonifying, diuresis and hepatoprotective effect, can make the leukocyte caused because of chemotherapy
Decline quantity to raise, and staphylococcus aureus, escherichia coli are had inhibitory action.
Radix Achyranthis Bidentatae: root is used as medicine, raw use, promoting blood circulation to restore menstrual flow;Ripe use, invigorating the liver and kidney, strong waist knee joint;Control soreness of waist and knee joint,
Caused by liver and kidney deficiency.Nature and flavor: bitter, sweet, sour are flat.Return liver, kidney channel.There is eliminating blood stasis and inducing menstruation, invigorating the liver and kidney, by force
Muscles and bones, inducing diuresis for treating stranguria syndrome, effect of conducting blood to flow downwards.
Radix Asparagi: tuber is conventional Chinese medicine, has nourshing Yin and drynsessmoistening prescription, to relieve inflammation or internal heat cough-relieving effect.Bitter in the mouth, flat, property
Cold, sweet and slightly bitter taste.Enter lung, kidney channel.Radix Asparagi root tuber extract, containing chemical compositions such as steroid saponins, has
Slow down aging, blood sugar lowering, antibacterial, the effect of antitumor, relieving cough and expelling phlegm.
Fructus Corni: for the drying and ripening sarcocarp of dicotyledon medicine Cornaceae plant Fructus Corni.Liver and kidney tonifying,
Arresting seminal emission reducing urination, consolidating channel for hemostasis, arresting sweating takes off admittedly." sour in the mouth is put down to mention it in " herbal classic "." " medicine
Justice " in mention it and " enter liver, the heart, kidney three warp.Fruit containing cornin, Saponin, tannin, ursolic acid,
The chemical compositions such as gallic acid, malic acid, tartaric acid and vitamin A.
Rhizoma Polygonati Odorati: " herbal classic ": part of being used as medicine for the rhizome of liliaceous plant Rhizoma Polygonati Odorati, its sweet in the mouth, flat, enter lung,
Stomach warp.Have yin nourishing, moisturize, heat clearing away, promote the production of body fluid, the effect such as cough-relieving.As tonic, cure mainly calentura
The diseases such as impairment of YIN, deficiency-heat cough caused by dryness, heart disease, diabetes, tuberculosis, and high-grade nourishing food, delicacies can be made
And beverage, with health role, it is worth vast farmers plantation.From Rhizoma Polygonati Odorati, extract flavonoid substances there is fall
Blood glucose, blood fat, blood pressure etc. act on.
Poria: for the dry sclerotia of On Polyporaceae Poria, sweet in the mouth, light, property is put down.GUIXIN, lung, spleen,
Kidney channel.Promoting diuresis to eliminate damp pathogen, spleen invigorating, mind calming.Mentioning in Compendium of Material Medica, Poria abnormal smells from the patient is light and oozes, its property
Up, born fluid, loosing the interspaces of skin and muscles, grow water source and decline, diuresis, therefore Zhang Jiegu calls its genus sun, floats and rises,
Say its property also;Dong Yuan call its for the YIN aspect of YANG, fall and under, Yan Qigong is also.Mentioning in " book on Chinese herbal medicine is just " can profit
Key dries, the then happy Fructus Alpiniae Oxyphyllae of profit key, leads turbid promoting the production of body fluid;Dry, dry spleen of relieving oedema or abdominal distension through diuresis or purgation, invigorating middle warmer stomach invigorating;Infantile convulsion,
Thick intestines and internal organs of the body, control expectorant originally, help the fall of medicine.Have with its taste micro-sweet, therefore say YANG invigorating.But mend few benefit.
Fructus Rubi: for the dry fruit of rosaceous plant rubus chingii Hu.Nature and flavor: sweet in the mouth, acid, warm in nature.
Gui Jing: return liver, kidney, bladder warp.There is supplementing the kidney to control the nocturnal reducing urination, effect of nourishing the liver to improve visual acuity." explaining abstruseness of the canon of materia medica "
In mention, " Fructus Rubi, sweet puts down into kidney, plays a sun and controls flaccidity, and controlling nocturnal emission with astringent drugs is taken the photograph excessive, and kidney tonifying without scorching partially, Gu
Smart and the most puckery evil, the product of gold and jade are also.
Fructus Lycii: for Chinese crude drug, sweet in the mouth, property is put down.Function tonification Liver and kidney, replenishing vital essence to improve eyesight." book on Chinese herbal medicine converges and says "
State Fructus Lycii: " the kind mesh of controlling of custom cloud Fructus Lycii, non-controls mesh also, can strengthen lean god, and god is full the most smart sufficient, therefore controls mesh
Effectively.Hardly realizing that Fructus Lycii can make gas to fill, blood can be mended, Yang Kesheng, and the moon can be grown, and fire can drop, and rheumatism can be gone,
Here there is perfect magical effect ".Modern pharmacology proves that Fructus Lycii has the effects such as hepatoprotective blood fat reducing.
Herb Gynostemmae Pentaphylli: for the herb of cucurbitaceous plant Herb Gynostemmae Pentaphylli.Bitter in the mouth;Micro-sweet;Cool in nature.Return lung;Spleen;Kidney
Warp.The main active ingredient of Herb Gynostemmae Pentaphylli be gypenoside, Herb Gynostemmae Pentaphylli glucoside (polysaccharide), water-soluble amino acid,
Flavonoid, multivitamin, trace element, mineral etc..To boil water with Herb Gynostemmae Pentaphylli or brew up, can treat
Hypertension, hyperlipidemia, hyperglycemia, the disease such as fatty liver.There are protecting liver and detoxication, lowering blood pressure and blood fat blood glucose
Effect.
Main advantages of the present invention include:
(1) traditional Chinese medical science think hyperglycemia, hyperlipidemia with deficiency and excess cause a disease, void person based on internal injury, have because of deficiency of qi and blood,
Kidney channel is not enough, brains lose foster caused;Reality person is with deficiency in origin and excess in superficiality for suffering from, and the spleen kidney lung heart all can cause a disease.Diet,
Seven emotions, overstrain, six climate exopathogens, heredity etc. can be all inducement.Wherein, the hyperglycemia traditional Chinese medical science i.e. " diabetes ", is reported
Compose deficiency, eating and drinking without temperance, disorder of emotion, labor are intended to the reason such as excessive and all may result in and quench one's thirst.Pathological changes internal organs are main
At lung, spleen, kidney, pathogenesis is mainly in YIN fluid deficiency, scorching inclined victory, and with the deficiency of YIN for this, scorching is mark,
Both results each other.Lung dryness of the stomach heat, deficiency of both QI and YIN, deficiency of kidney-YIN, negative and positive two are mainly had the symptom such as to lose.Adjust
Reason principle is nourishing yin and warming yang, the kidney invigorating fixation, clearing heat and moistening dryness, YIN nourishing and the production of body fluid promoting.Hyperlipemia in theory of Chinese medical science
The cause of disease includes: intemperance of taking food, addiction delicious food savoury, dyspepsia gastrointestinal, and temper is stranded, and the clearing heat in QI system of spleen can not be changed
Turbid, cause the turbid arteries and veins of being detained of expectorant to be sent out for primary disease;Love ease and hate work, enjoy a high position and live in ease and comfort, stagnation of QI-blood, hypoactivity of spleen-YANG,
Dysfunction of the spleen in transportation and transformation, causes the obstacle that cream fat generates and converts;Feelings will is not smooth, and seven emotions are caused a disease, the interior invading five ZANG-organs, then
Gas, blood, Tianjin, liquid dysfunction of the spleen in transportation and transformation, the cause defeated cloth of cream fat, transporting obstacle form hyperlipemia;Natural endowment is not
Foot, or old deficiency of kidney-essence, the main water of kidney, then body fluid Metabolic disorder of suffering from a deficiency of the kidney, cause cream fat transit barrier.Primary disease
Generation dirty with liver,spleen,kidney three in close relations, the dirty functional disorder of liver,spleen,kidney three is this.The traditional Chinese medical science is nursed one's health
Stress depressed liver-energy dispersing and function of gallbladder promoting, Qinghua is damp and hot is main.
(2) using antipyretic, convergence according to the above theoretical present invention, to improving hyperglycemia, hyperlipidemia has special merit
The Xiang Tianguo of effect is major function raw material.
(3) from nursing one's health, liver,spleen,kidney three is dirty starts with, and coordinates its liver controlling conveyance and dispersion with Fructus Corni, Radix Achyranthis Bidentatae, Fructus Lycii,
QI movement being in harmonious way contributes to transporting and the lucid yang sending up of spleen;Damp and hot with Rhizoma Polygonati Odorati, Herb Gynostemmae Pentaphylli, Poria soothing liver and strengthening spleen, Qinghua
Coordinating the transporting of spleen, the lucid yang sending up contributes to again the catharsis liter of liver and sends out;Liver spleen is in harmonious proportion, the transporting of essence of water and grain, defeated
Cloth is normal, then phlegm-damp is difficult raw, and sick peace is always;Its kidney controlling essence storage is coordinated, for elder generation with Radix Asparagi, Fructus Ligustri Lucidi
It this, the strong fortune of spleen, metaplasia is precise and tiny, must be by means of the warm of kidney yang and the nourishing of kidney yin;And essence in kidney
Gas also depends on the cultivation of the essence of water and grain day after tomorrow and supplements nutrition, and could constantly fill and ripe.The liver and the kidney have a common source, liver
Blood is kidney essense institute metaplasia, and the moon of fainting must treat that the essence foot of few the moon can be inflated smooth by blood, free flow of qi.
(4) capsule preparations of the present invention, is convenient for carrying and preserves.
Below in conjunction with specific embodiment, the present invention is expanded on further.Should be understood that these embodiments are only used for
The bright present invention rather than restriction the scope of the present invention.The experiment side of unreceipted actual conditions in the following example
Method, generally according to normal condition, or according to the condition proposed by manufacturer.Unless otherwise indicated, otherwise
Percentage ratio and number are percentage by weight and parts by weight.
Embodiment 1
The preparation of described health product
(1) orientation sky fruit 120g, Fructus Ligustri Lucidi 210g, Radix Achyranthis Bidentatae 500g are mixed, pulverize as mixed after coarse grain
Close, obtain mixture A;By ethanol solution reflux, extract, 3 times, the addition of ethanol solution is respectively mixture
10 times of A gross mass, 7 times and 3 times, reflux extracting time is respectively 2 hours, 1 hour and 30 minutes,
The mass fraction of ethanol solution is 65%;The alcohol extract of gained 50~70 DEG C temperature is concentrated in vacuo, with
And under the vacuum of-0.1Mpa, concentrated by decompression or vacuum, thus obtain alcohol extraction concentrated solution;It
After, at a temperature of the vacuum drying of 40~80 DEG C, under the vacuum of-0.1Mpa, alcohol extraction concentrated solution is done
Dry 24h, it is thus achieved that the dry extract (i.e. extract I) of moisture less than 20%.
(2) medicinal residues after alcohol extraction add in step (1) Radix Asparagi 630g, Fructus Corni 210g, Rhizoma Polygonati Odorati
95g, Poria 280g, Fructus Rubi 220g, Fructus Lycii 210g, Herb Gynostemmae Pentaphylli 270g, obtain mixture B, to mixing
Thing B water carries 3 times, and the amount of water that three water carries is respectively 10 times of mixture B gross mass, 8 times and 4
Times, carrying out for the first time water in advance mixture B is soaked in advance 1 hour, the time that 3 water carries is respectively
3 hours, 2 hours and 1 hour;Last Aqueous extracts the temperature being concentrated in vacuo of 60~80 DEG C,
Under the vacuum of-0.1Mpa, by reducing pressure or being concentrated in vacuo to thick extractum, the density of the thick extractum of gained is
1.35, afterwards at a temperature of the vacuum drying of 60~80 DEG C, under the vacuum of-0.1Mpa, thick extractum is done
Dry 24 hours, obtain dry extract (i.e. extract II).
(3) powder process: the extract II that extract I step (1) obtained and step (2) obtain, pulverizes,
Cross 60 mesh sieves, obtain extract powder, according to part by weight 2:1 mix homogeneously, be capsule filling;
(4) finished product is made: after the capsule filling that step (3) obtains being mixed with excipient substance microcrystalline Cellulose
Load capsule, packaging, obtain health product of the present invention (capsule).
Embodiment 2
Give 20 respectively by obtained sample (capsule of embodiment 1) and hyperglycemia occurs and with high blood
The patient of fat symptom takes, and twice daily, each 1g, after taking 30 days, 20 patients have and substantially change
Kind sensation, effect is satisfactory.
Embodiment 3
Zhang, women, 75 years old, dizziness occurred after fatigue before 2 years, accompanies distending pain in the head, top-heavy sense, companion
Feeling sick without vomiting, accompany tinnitus, ignore thing and rotate, after rest, symptom is without substantially alleviating, then to hospital admission.
Being diagnosed as type ii diabetes and hyperlipemia, be once interrupted drug administration hypoglycemic, existing non-rule is taken medicine,
Blood fat, poor blood glucose control.Take the capsule of embodiment 1, twice daily, each 1g, take 30 days
After, the state of an illness is obviously improved, and effect is satisfactory.
Embodiment 4
Liu, 38 years old, male, due to long-term diet outside, drinks uncontrolled, lacks motion, cause
Body weight 188 jin, the too high impaired glucose tolerance of long-term blood glucose value, it is diagnosed as hyperlipidemia and type ii diabetes,
Control the state of an illness after drug administration hypoglycemic, but Long-term taking medicine bring to life constant, several times make great efforts fat-reducing,
But all end in failure.Take the capsule of embodiment 1, twice daily, each 1g, after taking 20 days,
Blood pressure and blood lipoid is stable, allow people pleasantly surprised be that body weight has cut 5 jin, effect is satisfactory.
Embodiment 5
High certain, man, 59 years old, in health check-up, find that fasting glucose is 1.4mmol/L the year before;Serum glycerol
Three fat are 6.38mmol/L;Serum low-density LP is 0.73mmol/L;Glucose in urine is ++++, often have
Cardiopalmus, nervous symptom;Hospital is diagnosed as hyperglycemia hypertension, hyperlipemia three-hypers and deposits, with heart disease, often
See weak, dynamic then from dropping sweat, breathe hard, poor appetite.Look into pale and tender tongue, white and thin fur, while there is indentation, deep pulse
The most unable, seek the tens of families of doctor, although every huge is taken medicine, but blood glucose blood pressure is the most up and down, extremely unstable
Fixed, patient heart is the most dejected.Take the capsule of embodiment 1, twice daily, each 1g, take 45
After it, checking in hospital, blood fat tends to normal, and blood pressure is steady, and post-prandial glycemia is 7.2mmol/L. spirit
Looks have greatly change, and nervous, cardiopalmus symptom is completely eliminated, and sleep, complexion take a favorable turn, and effect makes us full
Meaning.
Embodiment 6
Jiang, 53 years old, suffers from diabetes more than ten years, type ii diabetes, with high blood ester, and visual deterioration,
Lumbago, dizzy, fatigue and weak, excessive thirst, numb limbs and tense tendons, skin pruritus.Take the capsule of embodiment 1,
Twice daily, each 1g, after taking 30 days, blood glucose starts to decline steadily, and tired phenomenon substantially alleviates,
Effect is satisfactory.
Embodiment 7
Wang, 46 years old, suffers from type Ⅱdiabetes mellitus 5 years, retinopathy, retinal hemorrhage, with hyperlipidemia,
Coronary heart disease, nephropathy, anasarca, fasting glucose 25 mMs rises, glucose in urine ++++, take various Chinese and Western
Medicine poor effect, the state of an illness increases the weight of the most day by day, after have no alternative but to use instead long term injections insulin and maintain, take enforcement
The capsule of example 1, twice daily, each 1g, after taking 30 days, blood glucose starts to decline steadily, and vision is extensive
Multiple, healthy and strong hale and hearty.
The all documents mentioned in the present invention are incorporated as reference the most in this application, just as each document
It is individually recited as with reference to like that.In addition, it is to be understood that after the above-mentioned teachings having read the present invention,
The present invention can be made various changes or modifications by those skilled in the art, and these equivalent form of values fall within this Shen equally
Please appended claims limited range.
Claims (10)
1. health product, it is characterised in that described health product contain the extract of raw material or raw material, its
Described in raw material include, wherein said raw material includes: Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, Radix Asparagi, mountain cornel
Meat, Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli,
Further, the weight portion of described raw material is as follows:
To sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae 2-8 part, Radix Asparagi 3-7 part, Fructus Corni 1-5
Part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part.
2. a combination for raw material, described combination include following raw material: Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae,
Radix Asparagi, Fructus Corni, Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli, and, the weight of described raw material
Amount part is as follows:
To sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae 2-8 part, Radix Asparagi 3-7 part, Fructus Corni 1-5
Part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part.
3. the purposes of the combination of raw material as claimed in claim 2, it is characterised in that be used for preparing reduction
Blood glucose and the health product of blood fat.
4. the preparation method of health product, it is characterised in that said method comprising the steps of:
(a) provide raw material, described raw material includes: Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, Radix Asparagi, Fructus Corni,
Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli,
Further, the weight portion of described raw material is as follows: to sky fruit 8-12 part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae
2-8 part, Radix Asparagi 3-7 part, Fructus Corni 1-5 part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5 part, Fructus Rubi 1-5
Part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part;
B () provides extract I and extract II;With
(c) mixed extract I and extract II, thus prepare described health product.
5. method as claimed in claim 4, it is characterised in that in step (b), be used for preparing extraction
The raw material of thing I includes: Xiang Tianguo, Fructus Ligustri Lucidi, Radix Achyranthis Bidentatae, and the weight portion of described raw material is as follows: to sky fruit 8-12
Part, Fructus Ligustri Lucidi 1-5 part, Radix Achyranthis Bidentatae 2-8 part.
6. method as claimed in claim 4, it is characterised in that in step (b), be used for preparing extraction
The raw material of thing II includes: Radix Asparagi, Fructus Corni, Rhizoma Polygonati Odorati, Poria, Fructus Rubi, Fructus Lycii, Herb Gynostemmae Pentaphylli, institute
The weight portion stating raw material is as follows: Radix Asparagi 3-7 part, Fructus Corni 1-5 part, Rhizoma Polygonati Odorati 1-3 part, Poria 1-5
Part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Herb Gynostemmae Pentaphylli 1-5 part.
7. method as claimed in claim 4, it is characterised in that in step (b), described extract I
Preparation include step:
I () is passed through for the raw material preparing extract I and is pulverized, add alcoholic solution and extract, obtain alcohol extract;
(ii) above-mentioned alcohol extract is concentrated, obtain alcohol extraction concentrated solution, be dried, thus obtain described extract I.
8. method as claimed in claim 4, it is characterised in that in step (b), described extract II
Preparation include step:
I the raw material being used for preparing extract II is added extraction in aqueous solution by (), obtain Aqueous extracts;
(ii) above-mentioned Aqueous extracts is concentrated, obtain water extracting liquid (thick extractum), be dried, thus carry described in obtaining
Take thing II.
9. method as claimed in claim 4, it is characterised in that in step (c), including step:
I () extract I, extract II mix, pulverize, sieve, obtain extract powder I and extract powder II respectively;
(ii) by extract powder I and extract powder II according to the ratio mix homogeneously of 2:1, and with pharmaceutically can connect
The carrier being subject to mixes, packaging, thus obtains described health product.
10. method as claimed in claim 9, it is characterised in that in described step (i), described extraction
After thing I and extract II co-grinding, cross 60 mesh sieves.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610304932.4A CN105943840A (en) | 2016-05-10 | 2016-05-10 | Health care product for reducing blood glucose and reducing fat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610304932.4A CN105943840A (en) | 2016-05-10 | 2016-05-10 | Health care product for reducing blood glucose and reducing fat |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105943840A true CN105943840A (en) | 2016-09-21 |
Family
ID=56914516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610304932.4A Pending CN105943840A (en) | 2016-05-10 | 2016-05-10 | Health care product for reducing blood glucose and reducing fat |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105943840A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1785310A (en) * | 2005-11-11 | 2006-06-14 | 范中举 | Chinese medicine for essence nourishing, bady building and hearth protection |
CN104000877A (en) * | 2014-05-30 | 2014-08-27 | 金鑫 | Blood glucose reducing composition and application thereof |
CN104623280A (en) * | 2015-02-06 | 2015-05-20 | 北京方中方科技有限公司 | Health product for reducing blood sugar and preparation method thereof |
CN104844682A (en) * | 2015-03-16 | 2015-08-19 | 李玉山 | Method for synergistically extracting and separating effective components of fructus swietenia macrophylla in cleaning manner |
-
2016
- 2016-05-10 CN CN201610304932.4A patent/CN105943840A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1785310A (en) * | 2005-11-11 | 2006-06-14 | 范中举 | Chinese medicine for essence nourishing, bady building and hearth protection |
CN104000877A (en) * | 2014-05-30 | 2014-08-27 | 金鑫 | Blood glucose reducing composition and application thereof |
CN104623280A (en) * | 2015-02-06 | 2015-05-20 | 北京方中方科技有限公司 | Health product for reducing blood sugar and preparation method thereof |
CN104844682A (en) * | 2015-03-16 | 2015-08-19 | 李玉山 | Method for synergistically extracting and separating effective components of fructus swietenia macrophylla in cleaning manner |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104435775B (en) | A kind of Traditional Chinese medicinal health-care wine and preparation method thereof | |
CN102988638B (en) | Cyclocarya paliurus blood-lipid and blood-sugar reducing health-care tea and preparation method thereof | |
CN101695376B (en) | Health-care food for preventing diabetes | |
CN102048933B (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
CN103053748B (en) | Kudzu vine root fat-reducing sugar-reducing health-care tea and preparation method thereof | |
CN103549052B (en) | Face beautifying and weight reduction tea and preparation method thereof | |
CN110447902B (en) | Composition with weight-losing effect | |
CN103860969A (en) | Traditional Chinese medicine for increasing weight | |
CN103405728B (en) | A kind of Chinese medicine composition for the treatment of climacteric syndrome and preparation method thereof | |
CN106562413A (en) | Oral thick paste for immunity enhancement and preparation method thereof | |
CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
CN105031517A (en) | Dendrobium officinale healthcare tea capable of reducing blood fat, blood sugar, and blood pressure and preparation method thereof | |
CN105079494A (en) | Dendrobium officinale capsule for lowering blood sugar and preparation method of dendrobium officinale capsule | |
CN105831543A (en) | Chrysanthemum health beverage with effects of calming liver and improving eyesight and preparation method thereof | |
CN105343593A (en) | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid | |
CN107125751A (en) | Tortoise powder, preparation method and applications | |
CN102552743A (en) | Medicinal composition for treating diabetes and preparation method thereof | |
CN105455125A (en) | Arillus longan oral solution capable of improving immunity, and preparation method for oral solution | |
CN104324229A (en) | Composition for relieving fatigue and preparation and application of composition | |
CN104606570A (en) | Consumptive thirst tea substitute drink suitable for diabetes patients and preparation method of consumptive thirst tea substitute drink | |
CN105943840A (en) | Health care product for reducing blood glucose and reducing fat | |
CN108853354A (en) | For qi-blood deficiency and beautifying face and moistering lotion composition and preparation method and purposes | |
CN111328967A (en) | Method for preparing health porridge for hyperlipidemia patients | |
CN108524861A (en) | A kind of traditional Chinese medicinal ointment and preparation method thereof for treating insomnia | |
CN102512642A (en) | Medicinal composition for treating spleen and stomach diseases and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180628 Address after: 201315 560, room 3, 2388 Xiu Pu Road, Pudong New Area, Shanghai. Applicant after: Shanghai Tzi Zhong Shang Pharmaceutical Co., Ltd. Address before: 201315 527, room 3, 2388 Xiu Pu Road, Pudong New Area, Shanghai. Applicant before: SHANGHAI TIANCI INTERNATIONAL PHARMACEUTICAL CO., LTD. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160921 |
|
RJ01 | Rejection of invention patent application after publication |